Supportive therapy for leukemia

Last medical review:

Supportive therapy is an important part of treatment for leukemia. It is given to treat complications from treatments and the leukemia itself. Some of these complications can include infection, bleeding and low blood cell counts.

Blood transfusions

Your healthcare team will check your blood cell counts during treatment. You will be given blood transfusions when needed to replace the blood cells you may have lost. The types of replacement transfusions used include:

  • red blood cells
  • platelets
  • fresh frozen plasma
  • cryoprecipitate (a product that replaces clotting factors)

Find out more about blood transfusions.

Growth factors

Growth factors (granulocyte colony-stimulating factors, or G-CSFs) may be used to stimulate the production of white blood cells. This shortens the length of time you will have a low white blood cell count and lowers the risk of infection.

Growth factors used in supportive therapy for leukemia may include filgrastim (Neupogen) and pegfilgrastim (Neulasta). These drugs may be given as a subcutaneous injection (just under the skin) or intravenously.

Treatment for tumour lysis syndrome

Tumour lysis syndrome (TLS) can be life-threatening and needs to be treated right away. It usually occurs at the start of chemotherapy when many tumour cells are destroyed rapidly. When the cells die, their contents are released into the bloodstream. This can create abnormally high levels of uric acid, potassium and phosphorus. TLS occurs when cancer cells break down so quickly that kidneys can't remove these substances from the blood fast enough.

The following treatments are used to lower the levels of these substances in the blood. These treatments may be given orally as a tablet or intravenously.

  • increased intravenous fluids
  • allopurinol (Zyloprim)
  • sodium bicarbonate
  • rasburicase (Fasturtec)

Find out more about tumour lysis syndrome.

Leukapheresis

Leukapheresis is a procedure that uses a special machine to remove large numbers of white blood cells from a sample of blood. The blood is then given back to the person. This may be done to lower a very high white blood cell count in people with leukemia.

Questions to ask about treatment

To make the decisions that are right for you, ask your healthcare team questions about treatment. For more detailed information on specific drugs, go to sources of drug information.

Expert review and references

  • Kareem Jamani, MD, LMCC, FRCPC
  • American Cancer Society. Treating Acute Lymphocytic Leukemia (ALL). 2021: https://www.cancer.org/.
  • National Comprehensive Cancer Network. NCCN Guidelines for Patients: Acute Lymphoblastic Leukemia. 2021: https://www.nccn.org/.
  • American Society of Clinical Oncology (ASCO). Cancer.net: Leukemia - Acute Lymphocytic - ALL. 2017:
  • Amgen Canada Inc.. Product Monograph: Neulasta. https://pdf.hres.ca/dpd_pm/00059540.PDF.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society